These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 18785974

  • 1. Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment.
    Pearson T, Shultz LD, Miller D, King M, Laning J, Fodor W, Cuthbert A, Burzenski L, Gott B, Lyons B, Foreman O, Rossini AA, Greiner DL.
    Clin Exp Immunol; 2008 Nov; 154(2):270-84. PubMed ID: 18785974
    [Abstract] [Full Text] [Related]

  • 2. Development of novel major histocompatibility complex class I and class II-deficient NOD-SCID IL2R gamma chain knockout mice for modeling human xenogeneic graft-versus-host disease.
    Pino S, Brehm MA, Covassin-Barberis L, King M, Gott B, Chase TH, Wagner J, Burzenski L, Foreman O, Greiner DL, Shultz LD.
    Methods Mol Biol; 2010 Nov; 602():105-17. PubMed ID: 20012395
    [Abstract] [Full Text] [Related]

  • 3. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells.
    Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S, Kotb M, Gillies SD, King M, Mangada J, Greiner DL, Handgretinger R.
    J Immunol; 2005 May 15; 174(10):6477-89. PubMed ID: 15879151
    [Abstract] [Full Text] [Related]

  • 4. Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma(null) mutation.
    Brehm MA, Cuthbert A, Yang C, Miller DM, DiIorio P, Laning J, Burzenski L, Gott B, Foreman O, Kavirayani A, Herlihy M, Rossini AA, Shultz LD, Greiner DL.
    Clin Immunol; 2010 Apr 15; 135(1):84-98. PubMed ID: 20096637
    [Abstract] [Full Text] [Related]

  • 5. A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene.
    King M, Pearson T, Shultz LD, Leif J, Bottino R, Trucco M, Atkinson MA, Wasserfall C, Herold KC, Woodland RT, Schmidt MR, Woda BA, Thompson MJ, Rossini AA, Greiner DL.
    Clin Immunol; 2008 Mar 15; 126(3):303-14. PubMed ID: 18096436
    [Abstract] [Full Text] [Related]

  • 6. Human immune system development and survival of non-obese diabetic (NOD)-scid IL2rγ(null) (NSG) mice engrafted with human thymus and autologous haematopoietic stem cells.
    Covassin L, Jangalwe S, Jouvet N, Laning J, Burzenski L, Shultz LD, Brehm MA.
    Clin Exp Immunol; 2013 Dec 15; 174(3):372-88. PubMed ID: 23869841
    [Abstract] [Full Text] [Related]

  • 7. NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells.
    Shultz LD, Lang PA, Christianson SW, Gott B, Lyons B, Umeda S, Leiter E, Hesselton R, Wagar EJ, Leif JH, Kollet O, Lapidot T, Greiner DL.
    J Immunol; 2000 Mar 01; 164(5):2496-507. PubMed ID: 10679087
    [Abstract] [Full Text] [Related]

  • 8. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.
    Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, Ueyama Y, Koyanagi Y, Sugamura K, Tsuji K, Heike T, Nakahata T.
    Blood; 2002 Nov 01; 100(9):3175-82. PubMed ID: 12384415
    [Abstract] [Full Text] [Related]

  • 9. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice.
    Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, Yoshimoto G, Watanabe T, Akashi K, Shultz LD, Harada M.
    Blood; 2005 Sep 01; 106(5):1565-73. PubMed ID: 15920010
    [Abstract] [Full Text] [Related]

  • 10. Human immune system development and rejection of human islet allografts in spontaneously diabetic NOD-Rag1null IL2rgammanull Ins2Akita mice.
    Brehm MA, Bortell R, Diiorio P, Leif J, Laning J, Cuthbert A, Yang C, Herlihy M, Burzenski L, Gott B, Foreman O, Powers AC, Greiner DL, Shultz LD.
    Diabetes; 2010 Sep 01; 59(9):2265-70. PubMed ID: 20570944
    [Abstract] [Full Text] [Related]

  • 11. Intrahepatic transplantation of cord blood CD34+ cells into newborn NOD/SCID-IL2Rγ(null) mice allows efficient multi-organ and multi-lineage hematopoietic engraftment without accessory cells.
    Navarro-Montero O, Romero-Moya D, Montes R, Ramos-Mejía V, Bueno C, Real PJ, Menendez P.
    Clin Immunol; 2012 Nov 01; 145(2):89-91. PubMed ID: 22964517
    [No Abstract] [Full Text] [Related]

  • 12. Cellular-based therapies to prevent or reduce thrombocytopenia.
    Pineault N, Boyer L.
    Transfusion; 2011 Nov 01; 51 Suppl 4():72S-81S. PubMed ID: 22074630
    [Abstract] [Full Text] [Related]

  • 13. Human nasal polyp microenvironments maintained in a viable and functional state as xenografts in NOD-scid IL2rgamma(null) mice.
    Bernstein JM, Brooks SP, Lehman HK, Pope L, Sands A, Shultz LD, Bankert RB.
    Ann Otol Rhinol Laryngol; 2009 Dec 01; 118(12):866-75. PubMed ID: 20112521
    [Abstract] [Full Text] [Related]

  • 14. Immunodeficient mouse strains display marked variability in growth of human melanoma lung metastases.
    Carreno BM, Garbow JR, Kolar GR, Jackson EN, Engelbach JA, Becker-Hapak M, Carayannopoulos LN, Piwnica-Worms D, Linette GP.
    Clin Cancer Res; 2009 May 15; 15(10):3277-86. PubMed ID: 19447870
    [Abstract] [Full Text] [Related]

  • 15. Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses.
    Watanabe S, Terashima K, Ohta S, Horibata S, Yajima M, Shiozawa Y, Dewan MZ, Yu Z, Ito M, Morio T, Shimizu N, Honda M, Yamamoto N.
    Blood; 2007 Jan 01; 109(1):212-8. PubMed ID: 16954502
    [Abstract] [Full Text] [Related]

  • 16. Humanized SCID mouse models for biomedical research.
    Pearson T, Greiner DL, Shultz LD.
    Curr Top Microbiol Immunol; 2008 Jan 01; 324():25-51. PubMed ID: 18481451
    [Abstract] [Full Text] [Related]

  • 17. Generation of Immunodeficient Mice Bearing Human Immune Systems by the Engraftment of Hematopoietic Stem Cells.
    Hasgur S, Aryee KE, Shultz LD, Greiner DL, Brehm MA.
    Methods Mol Biol; 2016 Jan 01; 1438():67-78. PubMed ID: 27150084
    [Abstract] [Full Text] [Related]

  • 18. Efficient xenoengraftment in severe immunodeficient NOD/Shi-scid IL2rγnull mice is attributed to a lack of CD11c+B220+CD122+ cells.
    Ito R, Katano I, Ida-Tanaka M, Kamisako T, Kawai K, Suemizu H, Aiso S, Ito M.
    J Immunol; 2012 Nov 01; 189(9):4313-20. PubMed ID: 23018460
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.